基石药业-B(02616.HK)：谢芳获委任为独立非执行董事

Core Viewpoint - 基石药业-B (02616.HK) announces the appointment of Xie Fang as an independent non-executive director and chairman of the audit committee, effective from November 1, 2025 [1] Group 1 - Xie Fang will also serve as a member of the remuneration committee, nomination committee, and investment committee [1] - He Yé has resigned from his positions as independent non-executive director, chairman of the audit committee, and member of the remuneration committee, nomination committee, strategic committee, and investment committee, effective at the end of business on October 31, 2025 [1]